Assura Plc (LON:AGR - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 46.62 ($0.63) and traded as high as GBX 49.32 ($0.67). Assura shares last traded at GBX 49.19 ($0.66), with a volume of 24,229,340 shares changing hands.
Assura Price Performance
The stock has a market capitalization of £1.60 billion, a price-to-earnings ratio of -47.10, a PEG ratio of 3.60 and a beta of 0.37. The company has a debt-to-equity ratio of 85.05, a quick ratio of 2.84 and a current ratio of 0.89. The company has a fifty day simple moving average of GBX 49.85 and a two-hundred day simple moving average of GBX 46.87.
Assura (LON:AGR - Get Free Report) last announced its quarterly earnings data on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. As a group, equities research analysts expect that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.
Insider Buying and Selling at Assura
In other Assura news, insider Jayne Cottam sold 94,230 shares of Assura stock in a transaction on Tuesday, July 22nd. The stock was sold at an average price of GBX 50 ($0.68), for a total value of £47,115 ($63,608.75). Also, insider Jonathan Murphy purchased 663 shares of the stock in a transaction dated Tuesday, August 5th. The shares were acquired at an average cost of GBX 49 ($0.66) per share, with a total value of £324.87 ($438.60). Insiders acquired a total of 2,540 shares of company stock valued at $125,674 over the last ninety days. Insiders own 8.35% of the company's stock.
Assura Company Profile
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Featured Articles
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.